Case Study

Genedata

7 pages
May 2006
Reference: IMD-1-0240

Venture Valuation conducts an independent valuation of Genedata, a Swiss start-up company in order to help Novartis Venture Fund analyze and structure the next financing round. Venture Valuation, under a tight investment timeframe, has to customize the evaluation process, using both quantitative and qualitative data, to meet the customers needs. The case outlines Genedata’s background, its product portfolio, competitive positioning, and issues that it will need to deal with in the near future. Learning Objective: This case is part of a three case series intended to draw the audience into the issues surrounding the valuation of a startup biotechnology company, one of the most speculative and volatile marketplace.

Keywords
Biotechnology, Valuation, Start-up, Genomics, Software, Development Stage Enterprise, Pharmaceuticals
Settings
Switzerland
2000-2005
Type
Field Research
Copyright
© 2005
Available Languages
English
Related material
Teaching note
Case clearing houses
IMD case studies are distributed through case clearing houses. In order to browse the collection and purchase copies please visit the links below.

The Case Centre

Cranfield University

Wharley End Beds MK43 0JR, UK
Tel +44 (0)1234 750903
Email [email protected]

Harvard Business School Publishing

60 Harvard Way, Boston MA 02163, USA
Tel (800) 545-7685 Tel (617)-783-7600
Fax (617) 783-7666
Email [email protected]

Asia Pacific Case Center

NUCB Business School

1-3-1 Nishiki Naka
Nagoya Aichi, Japan 460-0003
Tel +81 52 20 38 111
Email [email protected]

Contact

Research Information & Knowledge Hub for additional information on IMD publications

This case study is part of a series
  • Genedata
  • Novartis Venture Fund: Valuation dilemmas
  • Venture Valuation AG: The genedata assignment
This case study is part of a series
  • Genedata
  • Novartis Venture Fund: Valuation dilemmas
  • Venture Valuation AG: The genedata assignment
Discover our latest research
IMD's faculty and research teams publish articles, case studies, books and reports on a wide range of topics
Novartis Venture Fund: Valuation dilemmas
By Benoit F. Leleux Victoria Kemanian Atul Pahwa and Katrin Siebenbürger Hacki
Case reference: IMD-1-0242 ©2005
Summary
The Novartis Venture Fund is considering investing into a start up,Genedata, and must take into account the valuation analysis by boththe start up ...
Reference IMD-1-0242
Copyright ©2005
Copyright owner IMD Copyright
Available Languages English
Contact

Research Information & Knowledge Hub for additional information on IMD publications

Venture Valuation AG: The genedata assignment
By Benoit F. Leleux Victoria Kemanian Atul Pahwa and Katrin Siebenbürger Hacki
Case reference: IMD-1-0241 ©2005
Summary
Venture Valuation conducts an independent valuation of Genedata, a Swiss start-up company in order to help Novartis Venture Fund analyze and struct...
Reference IMD-1-0241
Copyright ©2005
Copyright owner IMD Copyright
Available Languages English
Contact

Research Information & Knowledge Hub for additional information on IMD publications